Sabaa International Company for Pharmaceutical and Chemical Industry (EGX:SIPC)
3.660
+0.040 (1.10%)
At close: Jun 4, 2026
EGX:SIPC Balance Sheet
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.91 | 0.61 | 0.42 | 0.15 | 4.87 |
Cash & Short-Term Investments | 1.91 | 0.61 | 0.42 | 0.15 | 4.87 |
Cash Growth | 212.35% | 44.30% | 183.26% | -96.93% | -39.65% |
Accounts Receivable | 24.34 | 4.9 | 7.95 | 7.54 | 11.42 |
Other Receivables | - | 0.42 | 0.07 | 0.75 | 1.62 |
Receivables | 24.34 | 14.07 | 8.99 | 13.9 | 13.09 |
Inventory | 39.81 | 42.24 | 50.45 | 32.3 | 28.85 |
Prepaid Expenses | - | - | - | 0.07 | 0 |
Other Current Assets | - | 5.55 | 2.89 | 0.12 | 1.35 |
Total Current Assets | 66.06 | 62.47 | 62.76 | 46.54 | 48.15 |
Property, Plant & Equipment | 102.95 | 106.28 | 107.37 | 109.16 | 107.46 |
Other Intangible Assets | 0.02 | 0.01 | 0.22 | - | - |
Long-Term Deferred Charges | - | - | - | 0.35 | 0.38 |
Total Assets | 169.02 | 168.76 | 170.35 | 156.05 | 155.99 |
Accounts Payable | 28.13 | 22.37 | 14.16 | 1.67 | 1.25 |
Accrued Expenses | - | 3.32 | 2.6 | 2.38 | 1.83 |
Short-Term Debt | 23.54 | 22.88 | 20.43 | 0.3 | 4.04 |
Current Portion of Long-Term Debt | - | 4.43 | 4.08 | - | - |
Current Portion of Leases | - | - | 0 | - | - |
Current Income Taxes Payable | 3.54 | 3.19 | 3.19 | 2.89 | 3.56 |
Other Current Liabilities | 5.69 | 10.31 | 6.05 | 12.2 | 9.26 |
Total Current Liabilities | 60.9 | 66.51 | 50.52 | 19.44 | 19.94 |
Long-Term Debt | - | 3.69 | 2.68 | 20.35 | 20.25 |
Long-Term Deferred Tax Liabilities | 2.5 | 1.64 | 2.21 | 1.19 | 0.24 |
Total Liabilities | 63.41 | 71.85 | 55.4 | 40.97 | 40.43 |
Common Stock | 100 | 100 | 100 | 100 | 100 |
Retained Earnings | 5.62 | -3.09 | 14.95 | 15.07 | 15.56 |
Shareholders' Equity | 105.62 | 96.91 | 114.95 | 115.07 | 115.56 |
Total Liabilities & Equity | 169.02 | 168.76 | 170.35 | 156.05 | 155.99 |
Total Debt | 23.54 | 31.01 | 27.19 | 20.64 | 24.28 |
Net Cash (Debt) | -21.63 | -30.4 | -26.76 | -20.49 | -19.42 |
Net Cash Per Share | -0.09 | -0.12 | -0.11 | -0.08 | -0.08 |
Filing Date Shares Outstanding | 258.45 | 250 | 250 | 250 | 250 |
Total Common Shares Outstanding | 258.45 | 250 | 250 | 250 | 250 |
Working Capital | 5.15 | -4.04 | 12.24 | 27.1 | 28.21 |
Book Value Per Share | 0.41 | 0.39 | 0.46 | 0.46 | 0.46 |
Tangible Book Value | 105.6 | 96.9 | 114.73 | 115.07 | 115.56 |
Tangible Book Value Per Share | 0.41 | 0.39 | 0.46 | 0.46 | 0.46 |
Land | - | 7.6 | 7.6 | 7.6 | 7.6 |
Buildings | - | 111.38 | 111.38 | 110.51 | 89.72 |
Machinery | - | 22.24 | 21.17 | 19.76 | 18.62 |
Construction In Progress | - | - | - | - | 16.49 |